Loading…

An in vitro assay system as a potential replacement for the histamine sensitisation test for acellular pertussis based combination vaccines

Abstract The histamine sensitisation test (HIST) for pertussis toxin is currently an official batch release test for acellular pertussis containing combination vaccines in Europe and North America. However, HIST, being a lethal endpoint assay, often leads to repeated tests due to large variations in...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2010-05, Vol.28 (21), p.3714-3721
Main Authors: Yuen, Chun-Ting, Horiuchi, Yoshinobu, Asokanathan, Catpagavalli, Cook, Sarah, Douglas-Bardsley, Alexandra, Ochiai, Masaki, Corbel, Michael, Xing, Dorothy
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract The histamine sensitisation test (HIST) for pertussis toxin is currently an official batch release test for acellular pertussis containing combination vaccines in Europe and North America. However, HIST, being a lethal endpoint assay, often leads to repeated tests due to large variations in test performance. Although a more precise HIST test based on measurement of temperature reduction after the histamine challenge is used in Asian countries, this test still uses animals. An in vitro test system based on a combination of enzyme coupled-HPLC and carbohydrate-binding assays with results analysed by a mathematical formula showed a good agreement with the in vivo HIST results based on measurement of temperature reduction after histamine challenge. The new in vitro test system was shown to be a potential alternative to the current in vivo HIST.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2010.03.009